New York, Jan. 9, 2023 /PRNewswire/ — DarioHealth Corp. (Nasdaq: DRIO) (“Dario” or the “Firm”), a pacesetter within the world digital therapeutics (DTx) market, introduced as we speak the publication of latest analysis within the peer-reviewed journal Utilized Sciences demonstrating improved outcomes for customers dwelling with diabetes throughout totally different racial and ethnic teams. The analysis seems within the journal as a part of the Particular Concern: Digital Therapeutics Functions for Persistent Illness Administration.
Dario’s built-in digital therapeutics platform engages customers dwelling with the most typical persistent situations utilizing a mixture of sensible instruments and applied sciences and human help to ship a extremely individualized expertise. The Firm’s platform is confirmed to assist customers enhance their well being and preserve outcomes over time.
Racial and ethnic disparities are widespread in lots of persistent situations together with diabetes. Digital well being has the chance to deal with these disparities and enhance outcomes. The brand new analysis examined retrospective information from 1,000 customers with Sort 2 diabetes who engaged with Dario’s platform throughout a 12-month interval. Information from customers who recognized as White was in comparison with the info of those that recognized as Black, Latino or Asian. The outcomes confirmed no statistical distinction within the ranges of engagement throughout racial and ethnic teams, and vital enhancements in common blood glucose between the primary and final month with no statistical distinction between racial and ethnic teams:
- 14% discount in White customers.
- 15% discount in Black, Latino and Asian customers.
“We’re thrilled to broaden our analysis on the vital matter of digital well being as a method to assist tackle well being inequities. We serve a various consumer inhabitants and bettering outcomes for everybody is at all times our aim. This new examine supplies assurance that our options have a optimistic scientific affect no matter race or ethnicity,” mentioned Yifat Hershcovitz, PhD, Vice President of Scientific and Scientific Affairs at Dario.
“Digital well being options might help bridge historic and structural divisions in conventional care, however to be broadly efficient, options should regularly look at bias and design for particular person variations. We’re excited to steer on this space and to share this new analysis demonstrating the effectiveness of Dario’s strategy and our potential to make higher well being accessible for everybody,” mentioned Omar Manejwala, MD, Chief Medical Officer at Dario.
The examine was performed in partnership with Marilyn D. Ritholz, PhD, Senior Psychologist, Joslin Heart for Diabetes; David L. Horwitz, President, DLH Biomedical Consulting; and Trisha Donaldson-Pitter, Educational Design Specialist/co-Lead of the Group Engagement, Outreach and Technical Help Core, UConn Well being Disparities Institute. You’ll be able to learn your complete examine right here.
About DarioHealth Corp.
DarioHealth Corp. (Nasdaq: DRIO) is a number one digital therapeutics (DTx) firm revolutionizing how individuals with persistent situations handle their well being via a user-centric multi-chronic situation platform. Our platform and suite of options ship customized and dynamic interventions pushed by information analytics and one-on-one teaching for diabetes, hypertension, weight administration, musculoskeletal ache, and behavioral well being.
Our user-centric platform provides individuals steady and customised take care of well being, disrupting the normal episodic strategy to healthcare. This strategy empowers individuals to holistically adapt their life for sustainable conduct change, driving distinctive consumer satisfaction, retention, and outcomes. Making the correct factor to do the straightforward factor to do.
Dario supplies its extremely consumer rated options globally to well being plans and different payors, self-insured employers, suppliers of care and on to shoppers. To study extra about DarioHealth and its digital well being options, or for extra data, go to http://dariohealth.com.
Cautionary Be aware Concerning Ahead-Wanting Statements
This information launch and the statements of representatives and companions of DarioHealth Corp. associated thereto include or could include forward-looking statements throughout the which means of the Personal Securities Litigation Reform Act of 1995. Statements that aren’t statements of historic reality could also be deemed to be forward-looking statements. For instance, the Firm is utilizing forward-looking statements on this press launch when it discusses the advantages derived from the usage of its merchandise and options, that its platform is confirmed to assist customers enhance their well being and preserve outcomes over time, and that the examine supplies assurance that its options have a optimistic scientific affect no matter race or ethnicity. With out limiting the generality of the foregoing, phrases corresponding to “plan,” “undertaking,” “potential,” “search,” “could,” “will,” “count on,” “imagine,” “anticipate,” “intend,” “might,” “estimate” or “proceed” are meant to determine forward-looking statements. Readers are cautioned that sure vital elements could have an effect on the Firm’s precise outcomes and will trigger such outcomes to vary materially from any forward-looking statements which may be made on this information launch. Components which will have an effect on the Firm’s outcomes embody, however are usually not restricted to, regulatory approvals, product demand, market acceptance, affect of aggressive merchandise and costs, product growth, commercialization or technological difficulties, the success or failure of negotiations and commerce, authorized, social and financial dangers, and the dangers related to the adequacy of present money sources. Further elements that would trigger or contribute to variations between the Firm’s precise outcomes and forward-looking statements embody, however are usually not restricted to, these dangers mentioned within the Firm’s filings with the U.S. Securities and Trade Fee. Readers are cautioned that precise outcomes (together with, with out limitation, the timing for and outcomes of the Firm’s industrial and regulatory plans for Dario™ as described herein) could differ considerably from these set forth within the forward-looking statements. The Firm undertakes no obligation to publicly replace any forward-looking statements, whether or not on account of new data, future occasions or in any other case, besides as required by relevant legislation.
Emblem – https://mma.prnewswire.com/media/1920436/DarioHealth_Logo.jpg
DarioHealth Company Contact
SOURCE DarioHealth Corp.